{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T13:55:40Z","timestamp":1794318940195,"version":"4.9.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This study was partly supported by Innovation Fund Denmark."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-09043-6","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T16:33:22Z","timestamp":1751387602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Neutrophil-mediated degradation of type III collagen is elevated in inflammatory bowel disease and DSS-induced colitis reflecting early mucosal damage"],"prefix":"10.1038","volume":"15","author":[{"given":"Thomai","family":"Tsapanou-Katranara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta S.","family":"Alexdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majken Lindholm","family":"Olesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Domislovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Christine","family":"Bay-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Asser","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017deljko","family":"Krznari\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kjeldsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Ainsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim H.","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"9043_CR1","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.3748\/wjg.v22.i3.1017","volume":"22","author":"E Liverani","year":"2016","unstructured":"Liverani, E., Scaioli, E., Digby, J., Bellanova, R., Belluzzi, A. & M. & How to predict clinical relapse in inflammatory bowel disease patients. World J. Gastroenterol. 22, 1017\u20131033 (2016).","journal-title":"World J. Gastroenterol."},{"key":"9043_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2022.733992","volume":"12","author":"P Qiu","year":"2022","unstructured":"Qiu, P. et al. The gut microbiota in inflammatory bowel disease. Front. Cell. Infect. Microbiol. 12, 1\u201314 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"9043_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2147\/JIR.S234710","volume":"13","author":"R Curciarello","year":"2020","unstructured":"Curciarello, R. et al. Human neutrophil elastase proteolytic activity in ulcerative colitis favors the loss of function of therapeutic monoclonal antibodies. J. Inflamm. Res. 13, 233\u2013243 (2020).","journal-title":"J. Inflamm. Res."},{"key":"9043_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells10102658","volume":"10","author":"A Kriaa","year":"2021","unstructured":"Kriaa, A. et al. Sp-1, a Serine protease from the gut microbiota, influences colitis and drives intestinal dysbiosis in mice. Cells 10, 1\u201321 (2021).","journal-title":"Cells"},{"key":"9043_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12664-022-01303-x","volume":"42","author":"E Cross","year":"2023","unstructured":"Cross, E., Saunders, B., Farmer, A. D. & Prior, J. A. Diagnostic delay in adult inflammatory bowel disease: A systematic review. Indian J. Gastroenterol. 42, 40\u201352 (2023).","journal-title":"Indian J. Gastroenterol."},{"key":"9043_CR6","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1053\/j.gastro.2020.08.005","volume":"159","author":"W Turpin","year":"2020","unstructured":"Turpin, W. et al. Increased intestinal permeability is associated with later development of crohn\u2019s disease. Gastroenterology 159, 2092\u20132100e5 (2020).","journal-title":"Gastroenterology"},{"key":"9043_CR7","first-page":"321","volume":"12","author":"B Drury","year":"2021","unstructured":"Drury, B., Hardisty, G., Gray, R. D. & Ho, G. tzer. Neutrophil extracellular traps in inflammatory bowel disease: pathogenic mechanisms and clinical translation. Cmgh 12, 321\u2013333 (2021).","journal-title":"Cmgh"},{"key":"9043_CR8","doi-asserted-by":"crossref","unstructured":"Saez, A., Herrero-Fernandez, B., Gomez-Bris, R., S\u00e1nchez-Martinez, H. & Gonzalez-Granado, J. M. Pathophysiology of inflammatory bowel disease: innate immune system. Int J. Mol. Sci 24, 1526 (2023).","DOI":"10.3390\/ijms24021526"},{"key":"9043_CR9","first-page":"1","volume":"9","author":"DR Hansberry","year":"2017","unstructured":"Hansberry, D. R., Shah, K. & Agarwal, P. Agarwal, N. Fecal myeloperoxidase as a biomarker for inflammatory bowel disease. Cureus 9, 1\u20137 (2017).","journal-title":"Cureus"},{"key":"9043_CR10","doi-asserted-by":"crossref","unstructured":"Fischbach, W. et al. Leucocyte elastase in chronic inflammatory bowel diseases: A marker of inflammatory activity? Digestion 37, 88\u201395 (1987).","DOI":"10.1159\/000199473"},{"key":"9043_CR11","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1160\/TH15-09-0710","volume":"115","author":"Z He","year":"2016","unstructured":"He, Z. et al. Phosphotidylserine exposure and neutrophil extracellular traps enhance procoagulant activity in patients with inflammatory bowel disease. Thromb. Haemost. 115, 738\u2013751 (2016).","journal-title":"Thromb. Haemost"},{"key":"9043_CR12","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/ecco-jcc\/jjy215","volume":"13","author":"V Dinallo","year":"2019","unstructured":"Dinallo, V. et al. Neutrophil extracellulartraps sustain inflammatory signals in ulcerative colitis. J. Crohn\u2019s Colitis. 13, 772\u2013784 (2019).","journal-title":"J. Crohn\u2019s Colitis"},{"key":"9043_CR13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/ecco-jcc\/jjz132","volume":"14","author":"T Li","year":"2020","unstructured":"Li, T. et al. Neutrophil extracellular traps induce intestinal damage and thrombotic tendency in inflammatory bowel disease. J. Crohn\u2019s Colitis. 14, 240\u2013253 (2020).","journal-title":"J. Crohn\u2019s Colitis"},{"key":"9043_CR14","unstructured":"Von Mark, D. K. Localization of collagen types in tissues. International Review of Connective Tissue Research vol. Vol. 9ACADEMIC PRESS, INC., (1981)."},{"key":"9043_CR15","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.addr.2003.08.002","volume":"55","author":"K Gelse","year":"2003","unstructured":"Gelse, K., P\u00f6schl, E. & Aigner, T. Collagens - Structure, function, and biosynthesis. Adv. Drug Deliv Rev. 55, 1531\u20131546 (2003).","journal-title":"Adv. Drug Deliv Rev."},{"key":"9043_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/00054725-200102000-00003","volume":"7","author":"IC Lawrance","year":"2001","unstructured":"Lawrance, I. C., Maxwell, L. & Doe, W. Inflammation location, but not type, determines the increase in TGF-\u03b21 and IGF-1 expression and collagen deposition in IBD intestine. Inflamm. Bowel Dis. 7, 16\u201326 (2001).","journal-title":"Inflamm. Bowel Dis."},{"key":"9043_CR17","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/ecco-jcc\/jjv123","volume":"9","author":"JH Mortensen","year":"2015","unstructured":"Mortensen, J. H. et al. Fragments of citrullinated and MMP-degraded vimentin and MMP-degraded type III collagen are novel serological biomarkers to differentiate crohn\u2019s disease from ulcerative colitis. J. Crohns Colitis. 9, 863\u2013872 (2015).","journal-title":"J. Crohns Colitis"},{"key":"9043_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/apt.14092","volume":"46","author":"WT van Haaften","year":"2017","unstructured":"van Haaften, W. T. et al. Misbalance in type III collagen formation\/degradation as a novel serological biomarker for penetrating (Montreal B3) crohn\u2019s disease. Aliment. Pharmacol. Ther. 46, 26\u201339 (2017).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"9043_CR19","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1097\/MIB.0000000000000863","volume":"22","author":"L Goffin","year":"2016","unstructured":"Goffin, L. et al. Anti-MMP-9 antibody: A promising therapeutic strategy for treatment of inflammatory bowel disease complications with fibrosis. Inflamm. Bowel Dis. 22, 2041\u20132057 (2016).","journal-title":"Inflamm. Bowel Dis."},{"key":"9043_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nargab\/lqz004","volume":"2","author":"N Maillet","year":"2020","unstructured":"Maillet, N. Rapid peptides generator: fast and efficient in Silico protein digestion. NAR Genomics Bioinforma. 2, 1\u201310 (2020).","journal-title":"NAR Genomics Bioinforma"},{"key":"9043_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF01551818","volume":"3","author":"ML Gefter","year":"1977","unstructured":"Gefter, M. L., Margulies, D. H. & Scharff, M. D. A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells. Somatic Cell. Genet. 3, 231\u2013236 (1977).","journal-title":"Somatic Cell. Genet."},{"key":"9043_CR22","unstructured":"Cox, K. L. et al. Immunoassay Methods Immunoassay Development, Optimization and Validation Flow Chart 2 Assay Guidance Manual. 1\u201339 (2019)."},{"key":"9043_CR23","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1007\/BF01303184","volume":"38","author":"SNS Murthy","year":"1993","unstructured":"Murthy, S. N. S. et al. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig. Dis. Sci. 38, 1722\u20131734 (1993).","journal-title":"Dig. Dis. Sci."},{"key":"9043_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1053\/j.gastro.2014.09.015","volume":"148","author":"B Pariente","year":"2015","unstructured":"Pariente, B. et al. Development of the L\u00e9mann index to assess digestive tract damage in patients with crohn\u2019s disease. Gastroenterology 148, 52\u201363e3 (2015).","journal-title":"Gastroenterology"},{"key":"9043_CR25","doi-asserted-by":"publisher","first-page":"6172","DOI":"10.3748\/wjg.v25.i41.6172","volume":"25","author":"L Gonczi","year":"2019","unstructured":"Gonczi, L., Bessissow, T. & Lakatos, P. L. Disease monitoring strategies in inflammatory bowel diseases: what do we mean by \u2018tight control\u2019? World J. Gastroenterol. 25, 6172\u20136189 (2019).","journal-title":"World J. Gastroenterol."},{"key":"9043_CR26","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.mam.2005.07.009","volume":"26","author":"Y Naito","year":"2005","unstructured":"Naito, Y. & Yoshikawa, T. Role of matrix metalloproteinases in inflammatory bowel disease. Mol. Aspects Med. 26, 379\u2013390 (2005).","journal-title":"Mol. Aspects Med."},{"key":"9043_CR27","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.clinbiochem.2010.03.012","volume":"43","author":"N Barascuk","year":"2010","unstructured":"Barascuk, N. et al. A novel assay for extracellular matrix remodeling associated with liver fibrosis: an enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen. Clin. Biochem. 43, 899\u2013904 (2010).","journal-title":"Clin. Biochem."},{"key":"9043_CR28","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.clinbiochem.2010.03.015","volume":"43","author":"MA Karsdal","year":"2010","unstructured":"Karsdal, M. A. et al. Novel combinations of Post-Translational modification (PTM) neo-epitopes provide tissue-specific biochemical markers-are they the cause or the consequence of the disease? Clin. Biochem. 43, 793\u2013804 (2010).","journal-title":"Clin. Biochem."},{"key":"9043_CR29","doi-asserted-by":"crossref","unstructured":"Deak, T. et al. Evidence that brief stress May induce the acute phase response in rats. Am J. Physiol. - Regul. Integr. Comp. Physiol 273, 1998-2004 (1997).","DOI":"10.1152\/ajpregu.1997.273.6.R1998"},{"key":"9043_CR30","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.bbr.2011.04.002","volume":"222","author":"J Simpson","year":"2011","unstructured":"Simpson, J. & Kelly, J. P. The impact of environmental enrichment in laboratory rats-Behavioural and neurochemical aspects. Behav. Brain Res. 222, 246\u2013264 (2011).","journal-title":"Behav. Brain Res."},{"key":"9043_CR31","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1007\/s10620-019-05676-6","volume":"64","author":"M Lindholm","year":"2019","unstructured":"Lindholm, M. et al. Extracellular matrix fragments of the basement membrane and the interstitial matrix are serological markers of intestinal tissue remodeling and disease activity in dextran sulfate sodium colitis. Dig. Dis. Sci. 64, 3134\u20133142 (2019).","journal-title":"Dig. Dis. Sci."},{"key":"9043_CR32","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10620-005-1292-y","volume":"50","author":"M Vicario","year":"2005","unstructured":"Vicario, M. et al. Induction of colitis in young rats by dextran sulfate sodium. Dig. Dis. Sci. 50, 143\u2013150 (2005).","journal-title":"Dig. Dis. Sci."},{"key":"9043_CR33","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s00535-022-01862-y","volume":"57","author":"M Kishi","year":"2022","unstructured":"Kishi, M. et al. A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation. J. Gastroenterol. 57, 246\u2013266 (2022).","journal-title":"J. Gastroenterol."},{"key":"9043_CR34","first-page":"21","volume":"9","author":"NE Walsham","year":"2016","unstructured":"Walsham, N. E. & Sherwood, R. A. Fecal calprotectin in inflammatory bowel disease. Clin. Exp. Gastroenterol. 9, 21\u201329 (2016).","journal-title":"Clin. Exp. Gastroenterol."},{"key":"9043_CR35","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1093\/ecco-jcc\/jjac047","volume":"16","author":"JH Mortensen","year":"2022","unstructured":"Mortensen, J. H. et al. A specific calprotectin Neo-epitope [CPa9-HNE] in serum from inflammatory bowel disease patients is associated with neutrophil activity and endoscopic severity. J. Crohn\u2019s Colitis. 16, 1447\u20131460 (2022).","journal-title":"J. Crohn\u2019s Colitis"},{"key":"9043_CR36","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1177\/2050640619834464","volume":"7","author":"TW Stevens","year":"2019","unstructured":"Stevens, T. W. et al. Diagnostic accuracy of faecal calprotectin in patients with active perianal fistulas. United Eur. Gastroenterol. J. 7, 496\u2013506 (2019).","journal-title":"United Eur. Gastroenterol. J."},{"key":"9043_CR37","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ejim.2007.04.026","volume":"19","author":"F Karadag","year":"2008","unstructured":"Karadag, F., Kirdar, S., Karul, A. B. & Ceylan, E. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Eur. J. Intern. Med. 19, 104\u2013108 (2008).","journal-title":"Eur. J. Intern. Med."},{"key":"9043_CR38","doi-asserted-by":"crossref","unstructured":"Liaskou, E., Wilson, D. V. & Oo, Y. H. Innate immune cells in liver inflammation. Mediators Inflamm. (2012). (2012).","DOI":"10.1155\/2012\/949157"},{"key":"9043_CR39","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.cgh.2008.06.010","volume":"6","author":"J Jones","year":"2008","unstructured":"Jones, J. et al. Relationships between disease activity and serum and fecal biomarkers in patients with crohn\u2019s disease. Clin. Gastroenterol. Hepatol. 6, 1218\u20131224 (2008).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"9043_CR40","doi-asserted-by":"publisher","first-page":"11246","DOI":"10.3748\/wjg.v21.i40.11246","volume":"21","author":"S Chang","year":"2015","unstructured":"Chang, S., Malter, L. & Hudesman, D. Disease monitoring in inflammatory bowel disease. World J. Gastroenterol. 21, 11246\u201311259 (2015).","journal-title":"World J. Gastroenterol."},{"key":"9043_CR41","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1002\/ibd.20178","volume":"13","author":"MA Denis","year":"2007","unstructured":"Denis, M. A., Reenaers, C., Fontaine, F., Bela\u00efche, J. & Louis, E. Assessment of endoscopic activity index and biological inflammatory markers in clinically active crohn\u2019s disease with normal C-reactive protein serum level. Inflamm. Bowel Dis. 13, 1100\u20131105 (2007).","journal-title":"Inflamm. Bowel Dis."},{"key":"9043_CR42","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1093\/ibd\/izz059","volume":"25","author":"DR Berg","year":"2019","unstructured":"Berg, D. R., Colombel, J. F. & Ungaro, R. The role of early biologic therapy in inflammatory bowel disease. Inflamm. Bowel Dis. 25, 1896\u20131905 (2019).","journal-title":"Inflamm. Bowel Dis."},{"key":"9043_CR43","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/joim.13345","volume":"290","author":"KR Herrlinger","year":"2021","unstructured":"Herrlinger, K. R. & Stange, E. F. Twenty-five years of biologicals in IBD: what\u00b4s all the hype about? J. Intern. Med. 290, 806\u2013825 (2021).","journal-title":"J. Intern. Med."},{"key":"9043_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2012.00107","volume":"3","author":"DC Rubin","year":"2012","unstructured":"Rubin, D. C., Shaker, A. & Levin, M. S. Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front. Immunol. 3, 1\u201310 (2012).","journal-title":"Front. Immunol."},{"key":"9043_CR45","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1038\/ajg.2010.248","volume":"105","author":"V Bergeron","year":"2010","unstructured":"Bergeron, V. et al. Risk factors for neoplasia in inflammatory bowel disease patients with pancolitis. Am. J. Gastroenterol. 105, 2405\u20132411 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"9043_CR46","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1080\/17474124.2019.1673729","volume":"13","author":"JH Mortensen","year":"2019","unstructured":"Mortensen, J. H. et al. The intestinal tissue homeostasis\u2013the role of extracellular matrix remodeling in inflammatory bowel disease. Expert Rev. Gastroenterol. Hepatol. 13, 977\u2013993 (2019).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"9043_CR47","unstructured":"Karsdal, M. A. Biochemistry of Collagens, Laminins and Elastin Structure, Function and Biomarkers (Elsevier, 2023)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09043-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09043-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09043-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T16:33:24Z","timestamp":1751387604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09043-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9043"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-09043-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"19 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TTK and MSA are full-time employees at Nordic Bioscience A\/S. MAK, ACBJ and JHM are full-time employees and stock owners at Nordic Bioscience A\/S. MLO was a former full-time employee at Nordic Bioscience A\/S. Nordic Bioscience A\/S is a privately owned medium-sized enterprise (SME) with expertise in biomarker discovery and development. VD, ZK, JK and MAA do not have competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21132"}}